| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -12,7 k € | -2.6% | -12,4 k € | +9.1% | -13,6 k € | +34.2% | -20,7 k € | -119.2% | -9,5 k € | +64.2% | -26,4 k € | +43.3% | -46,6 k € | -57.0% | -29,7 k € | -134.6% | 85,8 k € | |
| EBITDA | -13,6 k € | -8.9% | -12,5 k € | +11.2% | -14,1 k € | +33.5% | -21,2 k € | -113.6% | -9,9 k € | +76.3% | -41,9 k € | +12.8% | -48,1 k € | -59.4% | -30,2 k € | -135.5% | 85,0 k € | |
| Operating profit | -30,3 k € | -3.8% | -29,1 k € | +41.2% | -49,6 k € | +13.9% | -57,6 k € | -21.6% | -47,4 k € | +61.1% | -121,8 k € | +13.6% | -141,0 k € | +14.8% | -165,5 k € | -62.4% | -101,9 k € | |
| Profit/loss | -30,3 k € | -3.8% | -29,2 k € | +41.2% | -49,6 k € | +13.9% | -57,6 k € | -21.6% | -47,4 k € | +61.1% | -121,8 k € | +13.6% | -141,0 k € | +14.8% | -165,5 k € | -62.3% | -101,9 k € | |
| Equity | -344,4 k € | -9.6% | -314,1 k € | -10.2% | -284,9 k € | -21.1% | -235,3 k € | -32.4% | -177,7 k € | -36.4% | -130,3 k € | -1442.2% | -8,4 k € | -106.4% | 132,6 k € | -51.3% | 272,5 k € | |
| Total assets | 7,5 k € | -67.6% | 23,2 k € | -40.4% | 39,0 k € | -47.8% | 74,6 k € | -34.6% | 114,1 k € | -28.7% | 160,1 k € | -43.4% | 282,9 k € | -4.5% | 296,2 k € | -20.7% | 373,6 k € | |
| Cash | 620,9 € | +348.3% | 138,5 € | -75.0% | 553,8 € | +66.2% | 333,2 € | -60.5% | 843,4 € | -71.3% | 2,9 k € | -70.2% | 9,9 k € | +268.4% | 2,7 k € | -30.6% | 3,9 k € | |
| Debts | 351,9 k € | +4.3% | 337,3 k € | +4.1% | 323,9 k € | +4.5% | 309,9 k € | +6.2% | 291,7 k € | +0.5% | 290,4 k € | -0.4% | 291,4 k € | +78.1% | 163,6 k € | +61.9% | 101,1 k € | |
Private limited company · Gent · incorporated on 10/03/2015
Private limited company loss-making in the latest fiscal year. Cash position rising (+348.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APCOR R&M is a Private limited company incorporated in 2015. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette